J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots
Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices initially focused on detecting and treating lung cancer. The healthcare giant said an additional $2.35 billion in payouts may be possible if Auris hits certain milestones. … Continue reading J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed